MedPath

The study on significance of comprehensive genome analysis for patients who are suspected hereditary cancer syndrome

Not Applicable
Conditions
hereditary cancer syndrome
Registration Number
JPRN-UMIN000053919
Lead Sponsor
Department of Clinical genetics, Juntendo University, Graduate School of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Final diagnosis as hereditary cancer syndrome can be reached by routine genetic testing provided by laboratory testing company. 2) Person who lack consent ability to this study including genetic testing (Representative consenter is required). 3) Person that research representative decides to be inappropriate as a subject

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath